Changes in left ventricular geometry during antihypertensive treatment

被引:33
作者
Salvetti, Massimo
Paini, Anna
Bertacchini, Fabio
Stassaldi, Deborah
Aggiusti, Carlo
Rosei, Claudia Agabiti
Bassetti, Davide
Agabiti-Rosei, Enrico
Muiesan, Maria Lorenza [1 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, Med ASST Spedali Civil Brescia 2, Brescia, Italy
关键词
Hypertension; Left ventricular hypertrophy; Regression; Echocardiography; Left ventricular mass (LVM); LV remodeling; Relative Wall thickness (RWT); Diuretics (D); Beta-blockers (BB); Calcium channel blockers (CCB); Angiotensin-converting enzyme inhibitors (ACE-I); Angiotensin receptor blockers (ARBS); CONVERTING ENZYME-INHIBITORS; AMBULATORY BLOOD-PRESSURE; CALCIUM-CHANNEL BLOCKER; RANDOMIZED DOUBLE-BLIND; II RECEPTOR BLOCKER; END-POINT REDUCTION; HYPERTENSIVE PATIENTS; CARDIAC-HYPERTROPHY; PROGNOSTIC IMPLICATIONS; LOSARTAN INTERVENTION;
D O I
10.1016/j.phrs.2018.06.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The reduction of echocardiographic left ventricular (LV) mass and the change toward a less concentric geometry during antihypertensive treatment are independently associated with a better prognosis. Blood pressure lowering treatment may reduce cardiac hypertrophy, although different effect on changes of LV mass have been reported among antihypertensive drug classes, while changes in echocardiographic evaluated LV geometry have not been systemically evaluated. It is not yet clear whether antihypertensive drugs may influence LV geometry. Our aim was to compare the effects of diuretics (D), beta-blockers (BB), calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin receptor blockers (ARBS) on relative wall thickness (RWT) in patients with hypertension on the basis of prospective, randomized comparative studies. Methods: MEDLINE, and the ISI Web of Sciences were searched for randomized clinical trials evaluating LV mass and geometry at baseline and end follow-up. We have performed a pooled pairwise comparisons of the effect of the 5 major drug classes on relative wall thickness changes, and of each drug class versus other classes statistically combined. Results: We selected 53 publications involving 7684 patients. A significant correlation was observed between percent changes from baseline to end of treatment in LV mass and those in systolic BP (r = 0.44, p < 0.001). Reduction of LV mass was significantly greater with CCB than with BB (P < 0.02) without other significant differences between drug classes. Percent changes in RWT were related to percent changes in LV mass/LVmass index (r = 0.68, p = 0.016) and of SBP (r = 0.64 p < 0.033). RWT decreased during treatment with all classes of drugs, except the combination of BB and D; the decrease of RWT was less with diuretics and sympatholytic drugs. Conclusions: In studies evaluating the effect of different classes of antihypertensive drugs on LV mass, the reduction of relative wall thickness seems to be less during treatment with diuretics.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 79 条
[11]  
CRUICKSHANK JM, 1992, J HUM HYPERTENS, V6, P85
[12]   Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study [J].
Cuspidi, C ;
Muiesan, ML ;
Valagussa, L ;
Salvetti, M ;
Di Biagio, C ;
Agabiti-Rosei, E ;
Magnani, B ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2002, 20 (11) :2293-2300
[13]   Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey [J].
Cuspidi, C ;
Ambrosioni, E ;
Mancia, G ;
Pessina, AC ;
Trimarco, B ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2002, 20 (07) :1307-1314
[14]   Studies on left ventricular hypertrophy regression in arterial hypertension:: A clear message for the clinician? [J].
Cuspidi, Cesare ;
Esposito, Arturo ;
Negri, Francesca ;
Sala, Carla ;
Masaidi, Meilike ;
Giudici, Valentina ;
Zanchetti, Alberto ;
Mancia, Giuseppe .
AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (04) :458-463
[15]   Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy [J].
Dahlof, B ;
Zanchetti, A ;
Diez, J ;
Nicholls, MG ;
Yu, CM ;
Barrios, V ;
Aurup, P ;
Smith, RD ;
Johansson, M .
JOURNAL OF HYPERTENSION, 2002, 20 (09) :1855-1864
[16]   REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES [J].
DAHLOF, B ;
PENNERT, K ;
HANSSON, L .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) :95-110
[17]   REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN PREVIOUSLY UNTREATED ESSENTIAL-HYPERTENSION - DIFFERENT EFFECTS OF ENALAPRIL AND HYDROCHLOROTHIAZIDE [J].
DAHLOF, B ;
HANSSON, L .
JOURNAL OF HYPERTENSION, 1992, 10 (12) :1513-1524
[18]   Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass:: the PICXEL study [J].
Dahlof, Bjoern ;
Gosse, Philippe ;
Gueret, Pascal ;
Dubourg, Olivier ;
de Simone, Giovanni ;
Schmieder, Roland ;
Karpov, Yuri ;
Garcia-Puig, Juan ;
Matos, Lajos ;
De Leeuw, Peter W. ;
Degaute, Jean-Paul ;
Magometschnigg, Dieter .
JOURNAL OF HYPERTENSION, 2005, 23 (11) :2063-2070
[19]   Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination - The REASON echocardiography study [J].
de Luca, N ;
Mallion, LM ;
O'Rourke, MF ;
O'Brien, E ;
Rahn, KH ;
Trimarco, B ;
Romero, R ;
De Leeuw, PW ;
Hitzenberger, G ;
Battegay, E ;
Duprez, D ;
Sever, P ;
Safar, ME ;
REASON Project .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (08) :660-667
[20]   Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients [J].
De Rosa, ML ;
Cardace, P ;
Rossi, M ;
Baiano, A ;
de Cristofaro, A .
JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (02) :133-140